{"id":10386,"date":"2019-11-08T13:30:00","date_gmt":"2019-11-08T19:30:00","guid":{"rendered":"https:\/\/shockwavemedical.com\/news\/shockwave-medical-to-participate-in-the-13th-annual-canaccord-genuity-medical-technologies-diagnostics-forum\/"},"modified":"2019-11-08T13:30:00","modified_gmt":"2019-11-08T19:30:00","slug":"shockwave-medical-to-participate-in-the-13th-annual-canaccord-genuity-medical-technologies-diagnostics-forum","status":"publish","type":"news","link":"https:\/\/shockwavemedical.com\/ja\/news\/shockwave-medical-to-participate-in-the-13th-annual-canaccord-genuity-medical-technologies-diagnostics-forum\/","title":{"rendered":"Shockwave Medical to Participate in the 13th Annual Canaccord Genuity Medical Technologies &amp; Diagnostics Forum"},"content":{"rendered":"\n<section id=\"block_c152c1e2871fbb9959a04d4be3c03d59\" class=\"block block--wysiwyg wysiwyg_styles u-bgColorNone container\">\n\t<div class=\"u-wysiwyg u-animation\">\n\t\t<p>SANTA CLARA, Calif., Nov. 08, 2019 (GLOBE NEWSWIRE) \u2014 Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today announced the company will participate in a fireside chat with analysts and investors at the upcoming 13th Annual Canaccord Genuity Medical Technologies & Diagnostics Forum being held Thursday, November 21, 2019 in New York, NY.<\/p>\n<div class=\"shell\">\n<div class=\"sp-content pr-content\">\n<p><strong>About Shockwave Medical, Inc.<\/strong><\/p>\n<p>Shockwave Medical is focused on developing and commercializing products intended to transform the treatment of calcified vascular disease by establishing a new standard of care with Intravascular Lithotripsy (IVL). IVL seeks to minimize trauma within the artery by delivering pulsatile sonic pressure waves locally to fracture both intimal and medial calcium in the artery wall, but pass through surrounding soft vascular tissue in a safe manner. To view an animation of the IVL procedure and for more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EyGoL6PF7W5tndvKqldX5-RZ_lDmR0Wdh29r4DPYCI7ycLe76rGB0fwHPjahx9c4RIjSF7O_EXEBHB214-XCuevFRhAcQ9vX53fvJ67b6Ss=\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">www.shockwavemedical.com<\/a>.<\/p>\n<p><strong>Media Contact:<br \/>\n<\/strong>Scott Shadiow<br \/>\n+1.317.432.9210<br \/>\n<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mpF-dtLN2SXhFzVIFEDDqd1O0qpSMIbwfAmoj5WBSTf_593iiQScJsJbHnvN1REjhq27Tum4OOPDCynQMUjtAIoO8C1lqPqRmVNw0nFgFkjGpBaX7sum_ZEfFWWSK49W\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">sshadiow@shockwavemedical.com<\/a><\/p>\n<p><strong>Investor Contact:<br \/>\n<\/strong>Debbie Kaster, Gilmartin Group<br \/>\n<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bF1pWgXtsdsVS7IXujNJhPvzO4Z_EZsxD4ZO2rQOQ9MF7r2Yj6Lys17WTV3Il7HS2AiUmR1yRQ__BK9diu3Q8zfyH4N7PtZg8lQuK1i7mJ18uURQBYzarnOIZze3cjfB\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">investors@shockwavemedical.com<\/a><\/p>\n<p>Source: Shockwave Medical, Inc.<\/p>\n<\/div>\n<\/div>\n<p>\u00a0<\/p>\n<div class=\"shell\"><\/div>\n\t<\/div>\n\t<\/section>","protected":false},"excerpt":{"rendered":"<p>Shockwave Medical, Inc. announced the company will participate in a fireside chat  at the upcoming 13th Annual Canaccord Genuity Medical Technologies &#038; Diagnostics Forum.<\/p>\n","protected":false},"featured_media":9944,"template":"","format":[],"meta":{"_acf_changed":true,"content-type":""},"disease-state":[],"news-topic":[],"product-tag":[],"specialty":[],"technology":[],"class_list":["post-10386","news","type-news","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/news\/10386","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/media\/9944"}],"wp:attachment":[{"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/media?parent=10386"}],"wp:term":[{"taxonomy":"disease-state","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/disease-state?post=10386"},{"taxonomy":"format","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/format?post=10386"},{"taxonomy":"news-topic","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/news-topic?post=10386"},{"taxonomy":"product-tag","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/product-tag?post=10386"},{"taxonomy":"specialty","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/specialty?post=10386"},{"taxonomy":"technology","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/technology?post=10386"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}